Palisade Capital Management LP raised its stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 36.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 244,354 shares of the financial services provider's stock after purchasing an additional 65,653 shares during the quarter. Palisade Capital Management LP owned about 0.58% of Trupanion worth $9,107,000 at the end of the most recent reporting period.
A number of other hedge funds have also bought and sold shares of TRUP. Balyasny Asset Management L.P. increased its stake in Trupanion by 368.2% during the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock valued at $40,548,000 after purchasing an additional 661,559 shares in the last quarter. BNP Paribas Financial Markets increased its stake in Trupanion by 170.7% during the 4th quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider's stock valued at $16,248,000 after purchasing an additional 212,545 shares in the last quarter. Freestone Grove Partners LP acquired a new position in Trupanion during the 4th quarter valued at approximately $7,776,000. First Trust Advisors LP acquired a new position in Trupanion during the 4th quarter valued at approximately $7,083,000. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Trupanion by 112.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 273,910 shares of the financial services provider's stock valued at $13,204,000 after acquiring an additional 144,828 shares during the last quarter.
Insider Buying and Selling at Trupanion
In other news, CEO Margaret Tooth sold 4,000 shares of the stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $45.86, for a total value of $183,440.00. Following the completion of the sale, the chief executive officer directly owned 118,784 shares in the company, valued at $5,447,434.24. This represents a 3.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, COO John R. Gallagher sold 4,000 shares of the stock in a transaction dated Thursday, May 29th. The shares were sold at an average price of $47.90, for a total transaction of $191,600.00. Following the completion of the sale, the chief operating officer owned 26,966 shares of the company's stock, valued at $1,291,671.40. This trade represents a 12.92% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,562 shares of company stock valued at $678,230 over the last ninety days. Corporate insiders own 5.42% of the company's stock.
Analysts Set New Price Targets
Several research firms have recently commented on TRUP. Lake Street Capital dropped their price objective on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a report on Friday, May 2nd. Piper Sandler upped their price objective on shares of Trupanion from $52.00 to $62.00 and gave the company an "overweight" rating in a report on Thursday. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $53.80.
Read Our Latest Stock Analysis on Trupanion
Trupanion Stock Performance
NASDAQ TRUP traded up $0.17 during mid-day trading on Friday, reaching $52.13. 630,495 shares of the stock were exchanged, compared to its average volume of 616,338. The business's 50 day moving average is $48.39 and its 200-day moving average is $43.69. Trupanion, Inc. has a 1 year low of $27.40 and a 1 year high of $57.90. The company has a market capitalization of $2.23 billion, a P/E ratio of -521.25 and a beta of 1.82. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.70 and a current ratio of 1.70.
Trupanion (NASDAQ:TRUP - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.05) by $0.02. Trupanion had a negative net margin of 0.32% and a negative return on equity of 1.33%. The firm had revenue of $341.98 million for the quarter, compared to the consensus estimate of $337.81 million. During the same period in the prior year, the firm posted ($0.16) earnings per share. The firm's quarterly revenue was up 11.7% compared to the same quarter last year. On average, equities research analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.
Trupanion Company Profile
(
Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Stories

Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.